Harry S. Palmin

Chief Financial Officer, Opexa Therapeutics.

Companies

Opexa TherapeuticsChief financial officer Sep 21, 2017 to Nov 20, 2023¹
Opexa TherapeuticsChief Opp. and Financial Offr Feb 5, 2019 to Jan 19, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Opexa Therapeutics0 shares³Nov 17, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 17, 2023Returned to company 125,000 shares of Opexa Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROpexa Therapeutics, Chief financial officer
2
SEC EDGAROpexa Therapeutics, Chief Opp. and Financial Offr
3
SEC EDGAROpexa Therapeutics shares after the filing of Nov 17, 2023